Patent · US Active

Method of Chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection

US11793849B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

SUN YAT-SEN UNIVERSITY · CN

Inventors

Weiwei Su · Shenyang, CN
Chong Liu · Longbeilingcun, CN
Qian Zhou · Beijing, CN
Peibo Li · Tangxia, CN
Wei Peng · Port Aransas, US
Yonggang Wang · Beijing, CN

Key dates

Filing date	Oct 6, 2021
Grant date	Oct 24, 2023
Priority date	—
Expiry date	Oct 6, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a new drug application of a Pithecellobium Clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter Baumannii (MDRAB), an MDR Pseudomonas Aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia Coli (ECO) and an ESBL-producing Klebsiella Pneumonia (KPN).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.